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ttp://dx.doi.org/10.1016/j.ajpath.2013.10.027Pulmonary hypertension (PH) is a disease of diverse etiology. Although primary PH can develop in the
absence of prior disease, PH more commonly develops in conjunction with other pulmonary pathologies.
We previously reported a mouse model in which PH occurs as a sequela of Pneumocystis infection in the
context of transient CD4 depletion. Here, we report that instead of the expected Th2 pathways, the Th1
cytokine IFN-g is essential for the development of PH, as wild-type mice developed PH but IFN-g
knockout mice did not. Because gene expression analysis showed few strain differences that were not
immune-function related, we focused on those responses as potential pathologic mechanisms. In
addition to dependence on IFN-g, we found that when CD4 cells were continuously depleted, but
infection was limited by antibiotic treatment, PH did not occur, conﬁrming that CD4 T cells are required
for PH development. Also, although CD8 T-cells are implicated in the pathology of Pneumocystis
pneumonia, they did not have a role in the onset of PH. Finally, we found differences in immune cell
phenotypes that correlated with PH, including elevated CD204 expression in lung CD11cþ cells, but
their role remains unclear. Overall, we demonstrate that a transient, localized, immune response
requiring IFN-g and CD4-T cells can disrupt pulmonary vascular function and promote lingering PH.
(Am J Pathol 2014, 184: 483e493; http://dx.doi.org/10.1016/j.ajpath.2013.10.027)Supported by NIH grants (R01-HL096464 and P20-GM103500), an M.J.
Murdock Charitable Trust equipment grant, and the Montana State Uni-
versity Agricultural Experimental Station.Pulmonary hypertension (PH) is a devastating disease with
complex etiology and, in all likelihood, diverse mechanisms
of pathology. A recent reclassiﬁcation of the types of PH
involves ﬁve major divisions, including forms associated
with speciﬁc causative agents (such as drugs), hypoxia, and
infectious agents (such as schistosomes).1 A common feature
of many of these agents is that they initiate local inﬂamma-
tion, which may act as a trigger for the development of
PH,2e4 even if the inﬂammation does not persist after the
manifestation of PH. However, there does not seem to be any
single inﬂammatory mediator responsible for the inﬂamma-
tory initiation of PH. For example, several immune cell types
(T cells, B cells, and macrophages) and inﬂammatory cyto-
kines (TGF-b, IL-1b, IL-6, RANTES, and IL-13) have been
implicated in various forms of PH.5e9
In the T helper 1 and T helper 2 (Th1 and Th2) paradigm,
CD4þ Th2 cells drive an immune response characterized by
the production of cytokines such as IL-4, IL-5, and IL-13, as
well as by secreted antibody (in particular, IgE).10 In several
studies using animal models, a strong case has been made
for a role of Th2 immune responses as instigators of PH. Forstigative Pathology.
.example, a Th2 response associated with sensitization to an
antigen and subsequent challenge with that antigen can
result in muscularization of smaller pulmonary arteries, and
this response is associated with CD4þ cells and IL-13.11
The protein resistin-like alpha (Retnla; alias cysteine-rich
secreted protein FIZZ1) can be induced by hypoxia
(which is associated with vascular remodeling12), but it is
also induced in Th2 immune responses; in some cases, the
Th2-associated molecule Retn1a appears to have a strong
association with vascular remodeling and resultant PH,13,14
which may be related to its induction by hypoxia, itself a
potent stimulator of vascular remodeling.14 An interesting
mouse model of PH associated with repeated inhalation of
spores of the fungus Stachybotrys chartarum also is asso-
ciated with the Th2 cytokines IL-4 and IL-5, but not the Th1
cytokine IFN-g.15 Finally, in what is probably one of the
best-known examples of PH in conjunction with an
Swain et alinfectious agent, schistosomiasis-induced PH appears to be
associated with the Th2 cytokine IL-13.16 Furthermore, IL-
13 is implicated in several other forms of PH.17
In contrast, Th1 immune responses, which are charac-
terized by the secretion of cytokines such as IFN-g and
TNF-a and activation of phagocytic macrophages, appear
to have little connection with the development of vascular
remodeling and PH. Despite a few reports of elevated
TNF-a in conjunction with clinical syndromes that include
PH,7,18 there is very little association of PH with the ca-
nonical Th1 cytokine, IFN-g, although there is one report
of IFN-g having a synergistic effect with other cytokines
on in vitro pulmonary vascular cell remodeling.19 Indeed,
this lack of effect is illustrated by the fact that IFN-g has
been used in clinical treatment of idiopathic pulmonary
ﬁbrosis,20 although with little effectiveness, even though
40% of patients with idiopathic pulmonary ﬁbrosis also
exhibit PH.21
Recently, we reported that PH developed in the aftermath
of a resolved Pneumocystis pneumonia in mice, in the
context of a transient depletion of CD4þ cells.22 At the time,
it was unclear which immune responses are involved in the
development of PH in that mouse model; although there
were elevated levels of Retnla (FIZZ1) in the bron-
choalveolar lavage ﬂuid (BALF) of mice that developed PH,
as well as some perivascular ﬁbrosis, IL-4 signaling was not
required for these developments.22 In the present study,
surprisingly, we found that the Th1 cytokine IFN-g is
absolutely required for the development of PH in this mouse
model, and that perivascular ﬁbrosis does not appear to be a
cause of PH. Furthermore, having previously established
that onset of PH in these mice is correlated with the resur-
gence of CD4þ T cells after depletion,22 with the present
study we have demonstrated that CD4þ cells are also
absolutely required for the development of PH.
Materials and Methods
Animals
Mostmice used in these experiments were raised in theAnimal
Research Facility Center at Montana State University, from
stock originally obtained from the Jackson Laboratory (Bar
Harbor, ME). The IFN-geknockout mice were on a BALB/c
background (stock no. 002286). STAT6 knockout mice on a
BALB/c background (stock no. 002828) and IL-12p40
knockout mice on a BALB/c background (stock no. 002694)
were purchased directly from the Jackson Laboratory. SCID
mice were raised from stock originally obtained from Charles
River Laboratories International (stock no. 236; Wilmington,
MA). In some cases, BALB/c and C57BL/6 mice were pur-
chased directly from the NIHeNational Cancer Institute
Mouse Repository (Frederick, MD). All animals were housed
in isolation rooms in high-efﬁciency particulate absorp-
tioneﬁltered ventilated cages, and received autoclaved mouse
chow and acidiﬁed water.484Mouse Depletion and Infection Regimens
Pneumocystis murina (originally obtained from The Trudeau
Institute, Saranac Lake, NY) was maintained by serial colo-
nization of SCID source mice. To inoculate experimental
mice, the lungs of infected source mice were homogenized, P.
murina nuclei were enumerated, and 107 P. murina organisms
were administered via intratracheal delivery to isoﬂurane-
anesthetized mice, as described previously.23 Mice were
depleted of speciﬁc cell populations by periodic intraperitoneal
injections of antibody. For short-term depletion of CD4þ cells,
300 mg of GK1.5 (antibody grown from hybridoma originally
obtained from ATCC, Manassas, VA) was injected at days
3, 0, þ3, and þ7, relative to the day of infection. With this
procedure, resurgence of CD4þ cells occurs at 18 to 24 days
after infection, initiating clearance of the P. murina infec-
tion.22 Wild-type BALB/c treated in this way are here referred
to as BALB-STD, and IFN-g knockout mice treated in this
way are referred to as IFN-geSTD (where STD stands for
short-term depletion). When continuous depletion of CD4þ
cells was required, this protocol was followed by twice weekly
doses of 300 mg GK1.5.
To determine whether Pneumocystis-associated PH can
occur in the absence of CD4þ T cells, groups of mice were
continuously depleted of CD4þ cells, infected with P. murina,
and the subsequent fungal infection was then cleared by
antibiotic administration. This was done by switching the mice
to a medicated chow containing 0.124% sulfamethoxazole and
0.025% trimethoprim (Sulfa-Trim formula 5TXS; Test Diet,
Richmond, IN) (SMX-TMP) at 19 days after infection, so that
clearance kinetics of P. murina were similar to those of the
groups with short-term depletion. The animals were then
assessed as described at 36 days after infection. In other ex-
periments, a group of BALB-STD mice were also depleted
continuously of CD8þ cells, with twice-weekly intraperitoneal
injections of 300 mg of the depleting antibody TIB-210
[BALB-STD (CD8)] (antibody from the TIB-210, hybrid-
oma; ATCC).
Physiological Measurements and Tissue Sampling
Right ventricular pressure (RVP) was measured by trans-
thoracic cannulation of pentobarbital-anesthetized animals, as
described previously.22 After measurement, anesthetized mice
were euthanized by exsanguination. Bronchoalveolar lavage
was then performed by nicking the trachea and lavaging the
lungs with 3 mL of PBS containing 3 mmol/L EDTA. A 100-
mL aliquot of each lavage was spun onto a slide using a
cytospin centrifuge, and stained with Dade Behring Diff-Quik
(Siemens Healthcare Diagnostics, Newark, DE), and another
small aliquot was taken for microscopic enumeration of cells
in BALF, using a hemocytometer. The remaining lavage
samplewas centrifuged at 900 g for 10minutes. Supernatant
aliquots were frozen at 80C for later analysis of soluble
mediators, and the pelleted cells were used for ﬂuorescence-
activated cell sorting analysis, as described below. At thisajp.amjpathol.org - The American Journal of Pathology
Pneumocystis and Pulmonary Hypertensiontime, the heart was also removed, and the relative RV mass
was determined, as described previously.22 In brief, the atria
were trimmed away from the heart, which was then weighed;
next, the RVwas cut away from the heart and weighed, as was
the remaining left ventricle (LV) and septum (S). Relative RV
mass (%) was calculated as [RV/(LV þ S)]  100.
Lung tissue was collected by ﬁrst tying off the small right
lobes of the lung with suture, cutting these lobes off, and
then infusing the single large left lobe with phosphate-
buffered formalin. This lobe was then immersed in the
formalin solution, and later processed for histology. In some
cases, the left lobe was instilled with OCT optimal cutting
temperature compound (Sakura Finetek, Torrance, CA),
quick frozen, and later used for cryostat sectioning and
immunostaining. The small right lobes were immediately
homogenized in PBS, and the homogenate was used for
enumeration of P. murina burden, as described previ-
ously.22 Aliquots of the homogenate were either directly
frozen in liquid nitrogen for later zymography or, before
freezing, were supplemented with EDTA for collagen
analysis or with complete protease inhibitors (P8340;
Sigma-Aldrich, St. Louis, MO) and phosphatase inhibitors
(P5726; Sigma-Aldrich) for Western blot analysis.
Flow Cytometry
BALF cells were resuspended in Fc block solution and
stained for cell surface antigens, as described previously.22
A variety of antibody cocktails were used. Typically, two
cocktails (each with three to six antibodies) were used to
stain for lymphocyte markers (CD4, CD8, CD19, CD3,
CD49b, and gd-TCR) and a tetramer speciﬁc for natural
killer T (NKT) cells. Natural killer (NK) cells were quan-
tiﬁed based on CD3, CD49bþ staining. A third cocktail
was used for macrophage surface antigens (CD11c, CD11b,
CD204, CD80, and CD23). Antibodies were from eBio-
science (San Diego, CA), BioLegend, (San Diego, CA), and
BD Biosciences (San Jose, CA). Separate acquisition
schemes and set-up single stain tubes were used for mac-
rophages and lymphocytes, because of the high auto-
ﬂuorescence of alveolar macrophages; acquisition was
performed on either an LSR II or FACSCanto ﬂow
cytometer (BD Biosciences). Analysis was performed using
FlowJo software version 9.6 (Tree Star, Ashland, OR).
Percentages of cell subset numbers were combined with cell
count and differential count data to obtain actual cell
number estimates.
Biochemical Assays
Soluble collagen was measured in lung homogenates using a
Sircol dye kit (Biocolor, Carrickfergus, UK), as described
previously.22 Concentrations of IFN-g, IL-13, CCL2, IL-
12p40, and granulocyte-macrophage colony-stimulating fac-
tor (GM-CSF) in BALF were determined using commercial
enzyme-linked immunosorbent assay kits (eBioscience).The American Journal of Pathology - ajp.amjpathol.orgGene Expression Analysis
Total RNA was collected from the lungs of BALB-STD and
IFN-geSTD mice, as well as from immunocompetent
BALB/c mice that were P. murinaeinfected but not depleted
of CD4 and from control uninfected BALB/c mice, at day 38
after infection, using a Qiagen (Valencia, CA) RNeasy maxi
kit procedure. RNA was evaluated using an RNA 6000
NanoChip assay on a 2100 Bioanalyzer instrument (Agilent
Technologies, Santa Clara, CA); only RNA with an RNA
integrity number of >7.5 was used for analysis. Total RNA
was ampliﬁed, biotin-labeled, and hybridized to GeneChip
Mouse 430A 2.0 genome arrays (Affymetrix, Santa Clara,
CA), using 500 ng total RNA and an Ambion MessageAmp
premier RNA ampliﬁcation kit (AM1792; Life Technologies,
Carlsbad, CA). The labeled cRNA was puriﬁed, fragmented,
and hybridized to the arrays at 45C for 16 hours with con-
stant rotational mixing at 60 rpm.Washing and staining of the
arrays was performed using a GeneChip ﬂuidics station 450
(Affymetrix). Arrays were scanned using a GeneChip scan-
ner 7G and GCOS software version 1.4 (Affymetrix).
Microarray data were analyzed using FlexArray software
version 1.5 (http://www.gqinnovationcenter.com/services/
bioinformatics/ﬂexarray/index.aspx?lZe, last accessed
September 24, 2010). Files in Affymetrix CEL format were
imported and normalized using GC robust multiarray
normalization (GC-RMA). Three data ﬁlters were applied: i)
signal intensities of at least 50 in one biological replicate; ii)
at least one condition called present by the GCOS software;
and iii) a fold change of at least 2 in any comparison. Sta-
tistical signiﬁcance between conditions was determined
using analysis of variance, resulting in a ﬁnal gene list of 406
genes. The log2 values were imported into Genesis software
version 1.7.524 for hierarchical clustering. Grouping genes
into simpliﬁed categories was performed using the generic
Gene Ontology GO slim set from the GO Consortium (http://
www.geneontology.org/GO.slims.shtml, last accessed
November 21, 2012). Total lung gene expression data of P.
murinaeinfected wild-type and IFN-geknockout mice are
available at Gene Expression Omnibus (GEO) (http://www.
ncbi.nlm.nih.gov/geo, accession number GSE51750).
Statistical Analysis
Preliminary group analysis was performed using Numbers
software version ’09 (Apple, Cupertino, CA). Final statis-
tical analysis with analysis of variance followed by Tukey’s
post hoc tests was performed using GraphPad Prism 6
software (Graph Pad Software, La Jolla, CA).
Results
IFN-g Is Necessary for PH Development
Because our previous studies with IL-4 receptor knockout
mice suggested that Th2 immune mechanisms may not be485
Figure 1 Under short-term CD4 depletion and P. murina infection,
STAT6 knockout mice (STAT6-STD) are not protected from developing PH. A:
RVP did not differ between BALB-STD and STAT6-STD mice. B: RV hyper-
trophy was present in both CD4-depleted strains. Data are representative of
two independent experiments and are expressed as means  SEM. n Z 4
or 5. *P  0.05, **P  0.01 versus control (CON).
Figure 2 Under short-term CD4 depletion and P. murina infection, PH
develops in wild-type BALB/c mice (BALB-STD, squares) but not in IFN-g
knockout mice (IFN-geSTD, circles). RVP became elevated (A), and
persistent RV hypertrophy developed (B), even as the P. murina infection
was cleared (C). A Pneumocystis count of approximately 25,000 (4.4 on a
log10 scale) is the limit of detection for this procedure. Data are repre-
sentative of three independent experiments and are expressed as
means  SEM. n Z 5. *P  0.05, **P  0.01.
Swain et alrequired for development of PH in our model, we repeated
these experiments in mice deﬁcient in the transcription
factor STAT6, the cellular pathway through which many
Th2 responses are mediated. As with the IL-4 receptor
knockout mice, the STAT6 signaling knockout mice were
not protected from development of PH in this experimental
model (Figure 1). Although RVP was slightly reduced,
compared with wild-type BALB-STD mice (Figure 1A), RV
mass was not signiﬁcantly different (Figure 1B).
For comparison, we performed similar experiments with
Th1-deﬁcient mouse strains in Th1-related molecules. The
cytokine IL-12 is important in driving development of Th1
responses, and (as we show below) the p40 subunit of this
molecule is signiﬁcantly elevated in the BALF of BALB-
STD mice. Although the p40 subunit of IL-12 can be either
antagonistic or supportive of Th1 actions,25 results with IL-
12p40 knockout mice did not differ from results with
BALB-STD mice (data not shown). In contrast, mice deﬁ-
cient in IFN-g clearly did not develop PH when subjected to
the same experimental procedure as wild-type BALB/c mice
(Figure 2).
Next, we characterized the onset of PH in BALB-STD
mice. An increase in RVP coincided with the beginning of
resurgence of CD4þ cells at 20 days after inoculation
(Figure 3) and continued through the 36-day measurement
period; there was no signiﬁcant change in RVP in IFN-
geSTD mice (Figure 2A). The change in RVP was
mirrored by signiﬁcant RV hypertrophy in BALB-STD
mice, but (as expected) there was no change in RV mass
in IFN-geSTD mice (Figure 2B). In contrast to these486physiological responses, there was no signiﬁcant difference
in the kinetics of clearance of P. murina; in both BALB-
STD and IFN-geSTD mice, P. murina levels were high-
est at 20 days after infection and had declined to residual
levels by 36 days after infection (Figure 2C).Cellular and Cytokine Inﬂammatory Responses Are
Distinctly Different in BALB-STD and IFN-geSTD Mice
Because the onset of Pneumocystis-associated PH is tied to
the immune response, and to CD4þ T cells in particular, we
selected three time points (20, 28, and 36 days after infection)
to more closely examine the development from baseline of a
differential immune response in BALB-STD mice (which
exhibit PH) and in IFN-geSTD mice (which do not). As
expected, given the broad and complex role of IFN-g in the
immune response, we observed many signiﬁcant differences
in the immune response in these two strains of mice
(Figure 3). As the immune response proceeded, there was a
greater alveolar inﬂux of total cells in the IFN-geSTD mice,
although the types of cells predominant in each strain differedajp.amjpathol.org - The American Journal of Pathology
Figure 3 Under short-term CD4 depletion and P. murina infection, the
inﬂux of pulmonary inﬂammatory cells differs distinctly between BALB-STD
mice (which develop PH) and IFN-geSTD mice (which do not develop PH).
Cell types counted included total lung cells; macrophages (Macs), poly-
morphonuclear cells (PMN), eosinophils (EOS), natural killer (NK) cells, and
gd T cells as percentage in BALF; and B cells, CD4þ T cells, CD8þ T cells, and
CD4þCD8þ cells. Important differences are described in the Results section.
Data are representative of three independent experiments and are
expressed as means  SEM. nZ 5. *P  0.05, **P  0.01, ***P  0.001,
and ****P  0.0001 versus control.
Figure 4 IFN-g (A) and IL-12p40 (B) levels were elevated at times in
BALF from BALB-STD mice, compared with IFN-geSTD mice (which do not
develop PH), whereas levels of IL-13 (C) and GM-CSF (D) were signiﬁcantly
lower. E: Levels of CCL2 did not differ signiﬁcantly between the two mouse
strains. Data are representative of three independent experiments and are
expressed as means  SEM. nZ 5. *P  0.05, **P  0.01, ***P  0.001,
and ****P  0.0001 versus control.
Pneumocystis and Pulmonary Hypertensiondistinctly. In the IFN-geSTD mice, there were signiﬁcantly
more macrophages and gd T cells, and marginally greater
numbers of neutrophils and eosinophils at the peak of the
inﬂammatory response (20 to 28 days after infection). In
contrast, the BALB-STD mice had relatively more NK cells
in the BALF at this time. There were no consistent differ-
ences in the numbers of NKT cells (data not shown). Reso-
lution of inﬂammation was more rapid in the IFN-geSTD
mice than in the BALB-STD mice. We had previously found
that inﬂammation was nearly resolved in BALB-STD mice
by 50 days.22 In the present study, at 36 days there was still a
persistent lymphocytic inﬂammation in BALB-STD mice,
but inﬂammation had already begun to recede in IFN-
geSTDmice. Numbers of B cells, CD4þ T cells, and double-
positive (CD4þCD8þ) T cells were signiﬁcantly higher inThe American Journal of Pathology - ajp.amjpathol.orgBALB-STD mice at 36 days (Figure 3). Notably, there were
greater numbers of alveolar CD8þ T cells than CD4þ T cells
in both strains of mice, although the absolute number of
CD8þ cells was higher in IFN-geSTD mice at 28 days.
Also as expected, there were substantial differences in the
pulmonary inﬂammatory cytokine environment during
Pneumocystis infection in these two mouse strains. IFN-g487
Figure 5 In representative images, perivascular inﬂammation lingers around larger pulmonary arteries adjacent to airways (arrowheads), and collagen
deposition (blue) in these areas is similar in BALB-STD (A), IFN-geSTD (B), and STAT6-STD (C) mice but is less than that in the control (D). Although slight
inﬂammation without collagen deposition remains around smaller arterioles near alveolar ducts (arrows) in P. murinaeinfected mice, it is similar in BALB-STD
(E), IFN-geSTD (F), and STAT6-STD (G) mice but is absent in the control (H). Original magniﬁcation, 200. Scale bar Z 50 mm (B and F).
Swain et alwas markedly elevated in BALB-STD mice at 20 and 28
days after infection, but rapidly dropped to baseline levels
by 36 days (Figure 4A). IL-12p40 is another cytokine that
may have Th1-type actions, but is reported to have other
immunomodulatory functions as well.26,27 Levels of IL-
12p40 increased at 20 days after infection in both strains;
IL-12p40 remained elevated in WT mice through 36 days
after infection, but had declined to baseline levels in IFN-
geSTD mice by day 36 (Figure 4B). The baseline level of
pulmonary IL-13 was higher in IFN-geSTD mice than in
BALB-STD mice, and in the latter, IL-13 fell to signiﬁ-
cantly lower levels at 30 to 36 days after infection
(Figure 4C); a slight increase in IL-13 in BALB-STD mice
at 20 days after infection did not reach statistical signiﬁ-
cance. It is also notable that levels of the cytokine GM-CSF,
important in development and recruitment of macrophages,
were signiﬁcantly higher in the IFN-geSTD mice over the
course of the measurement period (Figure 4D), which may
in part explain the higher numbers of alveolar macrophages
noted above. Levels of CCL-2, another cytokine implicated
in the pulmonary recruitment of macrophages, did not differ
signiﬁcantly between the two mouse strains (Figure 4E).
Perivascular Fibrosis Is Not Correlated with PH
We previously observed areas of perivascular ﬁbrosis in
lungs of mice with PH.22 In the present study, we similarly
observed residual areas of perivascular inﬂammation, with
some indication of ﬁbrosis, as shown by collagen deposition
(Figure 5). However, this response was similar in BALB-
STD, IFN-geSTD, and STAT6-STD mice, compared with
controls (Figure 5, AeD). Because pressure regulation in
the pulmonary blood ﬂow may be related more to the caliber488of smaller arterioles, we also looked at arterioles near
alveolar ducts. Less residual inﬂammation was observed
near these smaller vessels, with no indication of perivascular
ﬁbrosis (Figure 5, EeH).
Gene Expression Analysis Shows a Mostly Differential
Immune Response
Analysis of total lung RNA of BALB-STD, IFN-geSTD,
and immunocompetent BALB/c Pneumocystis-infected
mice was made in comparison with RNA from BALB/c
control untreated mice. Using the criteria described above,
from the array of 14,000 possible genes, we identiﬁed 211,
360, and 111 genes, respectively in those three strains, that
demonstrated a twofold or greater change in expression. To
facilitate evaluation of the expressed genes from a larger
perspective, we categorized the genes into a deﬁned subset
of Gene Ontology groups (generic GO Slim). As expected,
the immune system process category had one of the largest
numbers of modulated genes, although large numbers of
modulated genes were found also in other categories,
including signal transduction, response to stress, and
anatomical structure development (Supplemental Table S1).
Because an immune response occurred in each of the
three groups, but PH was persistent only in the BALB-STD
group, we compared the three lists to determine what unique
genes, if any, are associated with PH. The BALB-STD
group had only two up-regulated genes and one down-
regulated gene unique to that group (Supplemental Table
S2); furthermore, these genes were only marginally greater
than twofold modulated, and their values differed only
slightly from the other two groups. We therefore ex-
panded our analysis to include genes that, although eitherajp.amjpathol.org - The American Journal of Pathology
Figure 6 Mice continuously depleted of CD4þ cells but treated with
SMX/TMP do not develop PH. Antibiotic treatment commenced at 20 days
after infection in P. murinaeinfected (PCþSMX) or uninfected (SMX only)
mice. At 40 days after infection, only the BALB-STD mice exhibited PH (A)
and RV hypertrophy (B). Numbers of CD4þ cells (C), CD8þ cells (D), mac-
rophages (E), and anti-Pneumocystis antibody (F) were measured in BALF.
Data are representative of two independent experiments and are expressed
as means  SEM. n Z 5. *P  0.05, **P  0.01, and ***P  0.001 as
compared to PCþSMX. OD, optical density 405 nm.
Pneumocystis and Pulmonary Hypertensionup-regulated or down-regulated in two or more groups,
exhibited much greater regulation (at least twofold) in one
group relative to the other two. This analysis allowed for a
greater number of genes to be considered (a total of 45)
(Supplemental Table S2). Most of these genes also reﬂect
the different immune response in the two strains. For
example, BALB-STD mice exhibited higher expression of
genes related to certain antibody subtypes (eg, IgG3), but
the IFN-geSTD mice had higher expression of CD8 and
CD3 antigens and some chemokines (CXCR6, CCL9). The
IFNeSTD mice also exhibited higher gene expression of
the matrix metallopeptidase MMP12; this was an intriguing
ﬁnding, but we could not detect any actual difference in
matrix metallopeptidase activity via zymography (data not
shown).
CD4þ T Cells Are Required for Development of PH
To demonstrate that the connection between CD4þ T cells
and the onset of PH in Pneumocystis-infected mice with
short-term depletion of CD4 is causal, and not simply
correlational, BALB/c mice were depleted of CD4þ cells for
the entire duration of an experiment. Because this would
normally result in fatal Pneumocystis pneumonia, at 20 days
after infection the mice were switched to lab chow containing
an antibiotic cocktail (SMX/TMP), to clear the Pneumocystis
infection. When the experiment was terminated at 40 days
after infection, Pneumocystis-infected mice with continuous
CD4 depletion and SMX/TMP treatment did not exhibit any
signiﬁcant signs of PH, in that neither RVP nor RV mass
differed signiﬁcantly from control untreated mice (Figure 6,
A and B). BALB-STD mice were the only group with
signiﬁcantly elevated CD4þ cells and macrophages
(Figure 6, C and E), but CD8þ cells were elevated in both of
the Pneumocystis-infected groups (Figure 6D). As has been
reviewed,28 signiﬁcant production of anti-Pneumocystis
antibody does not occur in the absence of CD4þ T cells
(Figure 6F).
CD8þ T Cells Are Not Implicated in Development of PH
In contrast to CD4þ depletion, when CD8þ cells were
depleted for the entire duration of the experiment, there was
no signiﬁcant difference in either RVP or RV hypertrophy,
compared with BALB-STD mice (Figure 7, A and B). This
was despite very little difference in the relative numbers of
other inﬂammatory cells when CD8þ cells were depleted
(Figure 7, C, E, and F).
Certain Immune Cell Phenotypes Correlate with PH
Although our results highlighted the necessity of CD4þ
T cells in the development of PH, we also examined
whether other immune cells, perhaps in response to CD4þ
cell actions, exhibit any phenotype unique to the BALB-
STD group and correlating with PH occurrence. The oneThe American Journal of Pathology - ajp.amjpathol.orggroup of cells that demonstrated consistent changes was
pulmonary CD11cþ cells (which in the lung includes both
alveolar macrophages and dendritic cells, as well as some
interstitial cells). In all experimental groups that exhibited
PH, CD11cþ cells had highly up-regulated expression of the
scavenger receptor CD204 (SR-A) (Figure 8). This up-
regulation was not present in CD11cþ cells in IFN-
geSTD mice, nor in mice subjected to continuous CD4
depletion (with antibiotic treatment), neither of which
exhibited PH. In contrast, when CD8þ cells were depleted,
there was up-regulation in CD11cþ CD204 expression,
correlating with PH in this group. This pattern was also
evident in CD11cþ cells obtained from digestion of the lung
(data not shown), which included interstitial cells as well as
alveolar cells.
Discussion
Although PH presents as a well-deﬁned set of distinct
symptoms, a number of different mechanistic pathways lead
to this disease. We present here a unique developmental
path of PH, in which an acute immune response to an in-
fectious organism leads to a chronic impairment after the
acute illness has been eliminated. We also show that it is the
context and quality of the immune response that determines
whether it will direct the onset of PH. The reconstitution of
immune function that occurred during an ongoing489
Figure 7 CD8þ cells do not contribute to the development of PH. Two
groups of mice were transiently depleted of CD4þ cells, and one group was
also continuously depleted of CD8þ cells [BALB-STD (CD8)]. There was no
signiﬁcant difference in PH (A), RV mass (B). Numbers of CD4þ cells (C),
CD8þ cells (D), macrophages (E), and B cells (F) were measured in BALF.
Data are representative of two independent experiments and are expressed
as means  SEM. nZ 5. **P  0.01 as compared to the BALB-STD (CD8)
group.
Figure 8 Up-regulated CD204 expression on lung CD11cþ cells corre-
lates with PH. Flow cytometric assessment of median ﬂuorescence intensity
(MFI) of Alexa Fluor 647econjugated anti-mouse CD204 on gated CD11cþ
BALF cells. Shown are comparisons of BALB-STD with IFN-geSTD (Figure 3),
PCþSMX (Figure 6), and BALB-STD (CD8) (Figure 7). Statistical tests were
performed on raw MFI values within each experiment, but values were
normalized (100% is the highest MFI of BALB-STD group, and 0% is the
mean CD204 MFI of control uninfected mice) for the composite graph. Data
are representative of two independent experiments and are expressed as
means  SEM. **P  0.01.
Swain et alPneumocystis infection after a transient period of partial
immunosuppression, although successful in eliminating the
pathogen, was aberrant in such a way as to cause long-term
deleterious effects on pulmonary vascular function.
In our previous study,22 the onset of PH in these mice was
correlated with the resurgence of CD4þ cells, and not with
the burden of Pneumocystis. Here, we conﬁrm that CD4þ
cells are required for the development of PH. Although
CD8þ T cells are known to be instrumental in pathology
accrued during terminal Pneumocystis pneumonia in the
absence of CD4þ cells,29 CD8þ cells are not implicated in
the development of PH in our experimental model, despite
the presence of large numbers of CD8þ cells in the lung
during the onset of PH. It is quite likely that the CD4þ cells
are not the proximal cause of changes to the pulmonary
vasculature, but instead determine the actions of other cells,
potentially other immune effector cells, that more directly
locally mediate whatever the vascular changes may underlie
PH, as discussed below. Indeed, our gene array analysis
conﬁrmed that most of the observed changes in pulmonary
gene expression are immune system related.
An immune-associated mechanism proposed in our pre-
vious study is that perivascular ﬁbrosis induced by inﬂam-
mation during clearance of Pneumocystis may be the
mechanistic link between the immune response and the
increased resistance in pulmonary blood ﬂow leading to RV
hypertrophy. At that time, we speculated that Th2-type490immune responses typically mediated through IL-4 and/or
IL-13 that are permissive to the development of ﬁbrosis may
be instrumental in the development of PH. However, just as
we previously showed that IL-4 signaling is not required for
PH, we show here that other Th2-associated pathways that
signal through STAT6 (IL-13 for example) were not
required for the development of PH. In fact, after using
several different mouse strains with genetic knockouts of
immune system components, we were surprised to ﬁnd that
the only factor we examined that was necessary for PH was
IFN-g, a Th1-type cytokine. Because slight amounts of
perivascular ﬁbrosis occurred in both IFN-geSTD and
wild-type mice in these experiments, we concluded that this
was probably a general response to the extended period of
inﬂammation coincident with the Pneumocystis infection in
the context of transient CD4 depletion, and thus was not a
strictly Th2-associated phenomenon. This also indicates
that, although there are compelling arguments that PH can
be associated with increased adventitial and/or smooth
muscle stiffness (a possible outcome of perivascular
ﬁbrosis),30 this was not a signiﬁcant factor in the PH we
observed in our experimental model.
The ﬁnding that IFN-g is required for the onset of PH in
our mouse model provided us with an experimental method
by which we could elucidate differences in both the immune
response and other downstream pulmonary changes instru-
mental in the development of PH. We observed several
obvious and consistent differences in the cellular inﬂam-
matory response between IFN-geSTD and BALB-STD
mice, such as increased numbers of macrophages and gd T
cells in IFN-geSTD mice and increased numbers of NK
and double-positive (CD4þCD8þ) lymphocytes in wild-
type mice. Although none of these cell types is known toajp.amjpathol.org - The American Journal of Pathology
Pneumocystis and Pulmonary Hypertensionhave a clear mechanistic connection to changes in the pul-
monary vasculature, some warrant further investigation. The
CD4þCD8þ cells are unusual, but they would presumably
be depleted with anti-CD8 injections; furthermore, because
this does not ameliorate PH, they probably are not mecha-
nistically involved. NK cells have recently been implicated
as potentially important effector cells in clearance of
Pneumocystis; they secrete IFN-g, and seem to be regulated
in those actions by CD4þ cells,31 which makes them
intriguing candidates for further investigation. Also,
although there are slightly fewer macrophage-type cells in
BALB-STD mice than in IFN-geSTD mice, we demon-
strated clear phenotypic differences in lung CD11cþ cells
that correlate with the development of PH, such as elevated
expression of the scavenger receptor CD204. Furthermore,
because IFN-g is known to promote production of reactive
oxygen species and reactive nitrogen species by macro-
phages, it will be crucial to explore whether the immune
response we observe may be causing vascular dysregulation
through oxidative mechanisms. An interesting parallel area
of investigation in the literature posits just such a mecha-
nism as involved in situations in which failure of trans-
planted tissue grafts occur because of failed blood supply to
the graft. These investigators showed that changes in the
production of NO by inducible NOS (iNOS) were disrupting
the function of endothelial NOS (eNOS), reducing the
ability of the arteries in these grafts to vasodilate, resulting
in decreased blood ﬂow and tissue damage. Most impor-
tantly, as in the present study, these effects were dependent
on both CD4þ T cells and IFN-g.32 Investigations are
currently under way in our research group to determine
whether these mechanisms are involved in our model of
immune response-associated PH.
Regarding other downstream changes in the lung, our gene
array data revealed very few signiﬁcant changes in pulmo-
nary gene regulation that were not immune-response related,
and those gene products identiﬁed do not as yet have any
obvious connection to PH. This paucity of results stands in
contrast to gene expression studies in other experimental PH
models. For example, hypoxic induction of PH in mice was
accompanied by a much greater diversity of gene expression
changes, including those with more direct involvement with
vascular remodeling.33 Furthermore, gene expression anal-
ysis of tissues taken from patients with primary PH also re-
veals a more diverse set of regulated genes than we found.34
This may indicate that the vascular dysfunction that we
describe is completely dependent on a lingering immune
response, however small, and that this response may even-
tually recede, given enough time. It is also possible that other,
nonimmune changes occurred that were highly local in nature
(ie, conﬁned only to perivascular regions in areas where
signiﬁcant inﬂammation occurred). In such a case, any
changes in nonimmune gene RNA expression might be
diluted out by sampling the entire lung tissue and therefore
would not be readily apparent in our assay. This type of
highly local response would probably instead result inThe American Journal of Pathology - ajp.amjpathol.orgdysregulation of vascular function, probably at the level of
vascular endothelium or smooth muscle, and would not
necessarily be reﬂected by overt vascular remodeling at the
histological level. This is in contrast to forms of PH, both in
humans and in animal models, that are characterized by
noticeable vascular remodeling, including medial hypertro-
phy and endothelial proliferation in the pulmonary vascula-
ture.35,36 However, the observation here and elsewhere37 that
PH can occur through vascular dysregulation in the absence
of signiﬁcant histological remodeling reinforces the notion
that there are many independent paths to persistent PH, and
raises the question whether sustained periods of immune-
induced vascular dysregulation may eventually lead to
other forms of vascular remodeling.
CD4-mediated pathology is believed to be important in
several clinical conditions, including allograft rejection,38
autoimmune disease,39 and immune reconstruction inﬂam-
matory syndrome (IRIS).40,41 The role of CD4þ cells in IRIS
is especially complex. Resurgence of CD4þ cells with
effector phenotypes and directed against residual pathogen
antigens (often with elevated serum IFN-g) is associated with
many outbreaks of IRIS.42 In contrast, late-onset IRIS-
associated Graves disease is associated with increased pro-
portions of naïve CD4þ cells.43 Other investigators have
proposed that resurgent CD4þ cells initiate IRIS symptoms
primarily through activation of accumulated innate immune
cells, such as macrophages.44 Although there is evidence that
some of these phenomena occur in our model of Pneumo-
cystis-associated PH (presence of antigen, modiﬁed CD4þ
phenotypes, modiﬁed macrophage phenotype), it remains to
be determined which CD4 actions facilitate the development
of PH. The larger question is the relevance of this model to
PH in HIV-infected individuals (HIV-PH). Given that the
incidence of HIV-PH is similar before and after highly active
antiretroviral therapy treatment,45 and that no signiﬁcant
correlation has yet been discovered between HIV-PH and
AIDS-related opportunistic diseases, it does not seem that the
pathological processes we demonstrated in mice are the pri-
mary cause of human HIV-PH. Nonetheless, the possibility
exists that these processes may be synergistic with other
mechanisms proposed for HIV-PH. For example, endothelial
dysfunction and increased pulmonary vascular tone, possibly
through increased stimulation of endothelin-1, have been
suggested as a mechanism of HIV-PH.46 If the inﬂammatory
processes we describe here occur in some AIDS patients, the
possibility exists for enhanced endothelial dysfunction
through additive effects of these mechanisms. Elucidation of
the speciﬁc mechanisms of vascular dysfunction in our model
will be required to determine the extent of this relevance to
human disease, and this is the goal of our ongoing efforts.Acknowledgments
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